Home » Topics » BioWorld Science

BioWorld Science
RSS

Zonagen initiates pivotal trials of Vasomax

Aug. 16, 1996

Andropatch marketed in U.K.

Aug. 16, 1996

BASF to manufacture Ares-Serono's hGH

Aug. 16, 1996

Antidiabetic potential of CDP-571 assessed, rejected in human trials

Aug. 16, 1996

Antidiabetic efficacy of ABB demonstrated in rats

Aug. 16, 1996

TheraTech studies oral mucosal delivery system for GLP-1

Aug. 16, 1996

Beta3 agonists reported by Dainippon

Aug. 16, 1996

HemoCleanse, VivoRx to collaborate on bioartificial liver device

Aug. 16, 1996

Hepagene efficacy confirmed in phase III

Aug. 16, 1996

Zadaxin filing in Taiwan appears imminent

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...